415 related articles for article (PubMed ID: 14707046)
1. Differential role of CCR2 in islet and heart allograft rejection: tissue specificity of chemokine/chemokine receptor function in vivo.
Abdi R; Means TK; Ito T; Smith RN; Najafian N; Jurewicz M; Tchipachvili V; Charo I; Auchincloss H; Sayegh MH; Luster AD
J Immunol; 2004 Jan; 172(2):767-75. PubMed ID: 14707046
[TBL] [Abstract][Full Text] [Related]
2. Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism.
Lee I; Wang L; Wells AD; Ye Q; Han R; Dorf ME; Kuziel WA; Rollins BJ; Chen L; Hancock WW
J Immunol; 2003 Dec; 171(12):6929-35. PubMed ID: 14662900
[TBL] [Abstract][Full Text] [Related]
3. The role of chemokines and their receptors in the rejection of pig islet tissue xenografts.
Solomon MF; Kuziel WA; Mann DA; Simeonovic CJ
Xenotransplantation; 2003 Mar; 10(2):164-77. PubMed ID: 12588649
[TBL] [Abstract][Full Text] [Related]
4. The contribution of chemokines and chemokine receptors to the rejection of fetal proislet allografts.
Solomon MF; Kuziel WA; Simeonovic CJ
Cell Transplant; 2004; 13(5):503-14. PubMed ID: 15565863
[TBL] [Abstract][Full Text] [Related]
5. The role of CC chemokine receptor 5 (CCR5) in islet allograft rejection.
Abdi R; Smith RN; Makhlouf L; Najafian N; Luster AD; Auchincloss H; Sayegh MH
Diabetes; 2002 Aug; 51(8):2489-95. PubMed ID: 12145162
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of chemokines and chemokine receptors in murine islet allografts: the role of CCR2 and CCR5 signaling pathways.
Schröppel B; Zhang N; Chen P; Zang W; Chen D; Hudkins KL; Kuziel WA; Sung R; Bromberg JS; Murphy B
J Am Soc Nephrol; 2004 Jul; 15(7):1853-61. PubMed ID: 15213273
[TBL] [Abstract][Full Text] [Related]
7. Donor-derived IP-10 initiates development of acute allograft rejection.
Hancock WW; Gao W; Csizmadia V; Faia KL; Shemmeri N; Luster AD
J Exp Med; 2001 Apr; 193(8):975-80. PubMed ID: 11304558
[TBL] [Abstract][Full Text] [Related]
8. Chemokines in islet allograft rejection.
Abdi R; Means TK; Luster AD
Diabetes Metab Res Rev; 2003; 19(3):186-90. PubMed ID: 12789651
[TBL] [Abstract][Full Text] [Related]
9. Requirement of the chemokine receptor CXCR3 for acute allograft rejection.
Hancock WW; Lu B; Gao W; Csizmadia V; Faia K; King JA; Smiley ST; Ling M; Gerard NP; Gerard C
J Exp Med; 2000 Nov; 192(10):1515-20. PubMed ID: 11085753
[TBL] [Abstract][Full Text] [Related]
10. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection.
Yun JJ; Whiting D; Fischbein MP; Banerji A; Irie Y; Stein D; Fishbein MC; Proudfoot AE; Laks H; Berliner JA; Ardehali A
Circulation; 2004 Feb; 109(7):932-7. PubMed ID: 14757698
[TBL] [Abstract][Full Text] [Related]
11. Organ-specific differences in the function of MCP-1 and CXCR3 during cardiac and skin allograft rejection.
Haskova Z; Izawa A; Contreras AG; Flynn E; Boulday G; Briscoe DM
Transplantation; 2007 Jun; 83(12):1595-601. PubMed ID: 17589343
[TBL] [Abstract][Full Text] [Related]
12. Prolonged allograft survival in TNF receptor 1-deficient recipients is due to immunoregulatory effects, not to inhibition of direct antigraft cytotoxicity.
McKee CM; Defina R; He H; Haley KJ; Stone JR; Perkins DL
J Immunol; 2002 Jan; 168(1):483-9. PubMed ID: 11751996
[TBL] [Abstract][Full Text] [Related]
13. Genetic deletion of chemokine receptor CXCR3 or antibody blockade of its ligand IP-10 modulates posttransplantation graft-site lymphocytic infiltrates and prolongs functional graft survival in pancreatic islet allograft recipients.
Baker MS; Chen X; Rotramel AR; Nelson JJ; Lu B; Gerard C; Kanwar Y; Kaufman DB
Surgery; 2003 Aug; 134(2):126-33. PubMed ID: 12947308
[TBL] [Abstract][Full Text] [Related]
14. Early chemokine cascades in murine cardiac grafts regulate T cell recruitment and progression of acute allograft rejection.
Morita K; Miura M; Paolone DR; Engeman TM; Kapoor A; Remick DG; Fairchild RL
J Immunol; 2001 Sep; 167(5):2979-84. PubMed ID: 11509648
[TBL] [Abstract][Full Text] [Related]
15. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG
J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279
[TBL] [Abstract][Full Text] [Related]
16. Chemokine and toll-like receptor signaling in macrophage mediated islet xenograft rejection.
Chandra AP; Ouyang L; Yi S; Wong JK; Ha H; Walters SN; Patel AT; Stokes R; Jardine M; Hawthorne WJ; O'Connell PJ
Xenotransplantation; 2007 Jan; 14(1):48-59. PubMed ID: 17214704
[TBL] [Abstract][Full Text] [Related]
17. Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection.
Gao W; Topham PS; King JA; Smiley ST; Csizmadia V; Lu B; Gerard CJ; Hancock WW
J Clin Invest; 2000 Jan; 105(1):35-44. PubMed ID: 10619859
[TBL] [Abstract][Full Text] [Related]
18. A novel small-molecule compound targeting CCR5 and CXCR3 prevents acute and chronic allograft rejection.
Akashi S; Sho M; Kashizuka H; Hamada K; Ikeda N; Kuzumoto Y; Tsurui Y; Nomi T; Mizuno T; Kanehiro H; Hisanaga M; Ko S; Nakajima Y
Transplantation; 2005 Aug; 80(3):378-84. PubMed ID: 16082334
[TBL] [Abstract][Full Text] [Related]
19. CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model.
Hüser N; Tertilt C; Gerauer K; Maier S; Traeger T; Assfalg V; Reiter R; Heidecke CD; Pfeffer K
Eur J Immunol; 2005 Jan; 35(1):128-38. PubMed ID: 15593118
[TBL] [Abstract][Full Text] [Related]
20. Permanent survival of fully MHC-mismatched islet allografts by targeting a single chemokine receptor pathway.
Wang L; Han R; Lee I; Hancock AS; Xiong G; Gunn MD; Hancock WW
J Immunol; 2005 Nov; 175(10):6311-8. PubMed ID: 16272282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]